DF II LP
ActiveSummary
DF II LP has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €58.8m and a net result of -€3.3m. Equity is growing by about 19% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).
Group and network
Holdings and subsidiaries
4 holdingsHoldings 4
Source for every holding own accounts 2024
- Equity €2.9mResult -€12.8m27.4%
- AMBAGON THERAPEUTICS IncUS16.51%
- FRONTIER MEDICINES INCUS14.16%
- VOLASTRA IncUS10.42%
According to the 2024 annual accounts of DF II LP and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 3 of 12 Gazette acts processed.